Tetravac

Tetravac is an inactivated poliovirus and pertussis vaccine designed to help protect against polio and whooping cough. This EU-manufactured vaccine is administered via intramuscular injection for broad immunization. It supports community immunity by targeting multiple pathogens in a single dose.

Tetravac is used to help prevent infections caused by poliovirus and Bordetella pertussis, the bacteria responsible for whooping cough. It is commonly administered as part of routine childhood immunization schedules to provide immunity against these diseases. The vaccine is intended for individuals seeking protection or booster doses for polio and pertussis.

After administration, Tetravac stimulates the immune system to produce antibodies against poliovirus and pertussis. This immune response helps the body recognize and fight these pathogens if exposed in the future. Most recipients experience mild effects like soreness at the injection site or mild fever.

Tetravac should be handled with care to maintain its potency and safety. It is important to store the vaccine at the recommended temperature and use it before the expiration date. Individuals with severe allergies to any component of the vaccine should consult a healthcare provider before use.

Tetravac may be administered alongside other vaccines, but simultaneous use should be evaluated by a healthcare professional. Certain medications, such as immunosuppressants, may affect the vaccine's effectiveness. Always inform your healthcare provider about any medications or conditions before vaccination.